1. Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Issue 5 (8th August 2021) Authors: Farrell, Sheila; Karp, Jacqueline; Hager, Rebecca; Wang, Yan; Adeniyi, Oluseyi; Wang, Jie; Li, Liang; Ma, Lian; Peretz, Jackye; Summan, Mukesh; Kong, Nicolas; White, Michael; Pacanowski, Michael; Price, Dionne; Filie, Jane; Donohue, Kathleen; Joffe, Hylton Journal: Journal of inherited metabolic disease Issue: Volume 44:Issue 5(2021) Page Start: 1085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗